Marihuana-Boom: Welche Aktien langfristig wirklich profitieren (Seite 9) | Diskussion im Forum

eröffnet am 25.11.18 18:51:49 von
neuester Beitrag 09.09.20 14:23:10 von


Beitrag schreiben

Begriffe und/oder Benutzer

 

Avatar
29.05.20 14:05:30
'Der Aktionär" hat Canopy als Basisinvestment...solche Pfeifen. Vielleicht ein paar Straßendealer in die Geschäftsführung, die haben vom Verkauf mehr Ahnung.
Canopy Growth | 15,54 €
Avatar
29.05.20 14:09:03
... oder die Geschäftsführung von Aurora Cannabis um Rat fragen
Das sind die gleichen Pfuscher.
Canopy Growth | 15,62 €
Avatar
29.05.20 15:00:08
Schlechter Zahlen,schade. Ichs haben zum Glück den Einstieg gut die nächste Woche geplant gehabt.
Canopy Growth | 15,90 €
Avatar
02.06.20 11:26:58
Mal sehen,wie weit es hier runter geht. Gedanken?
Canopy Growth | 14,75 €
Avatar
04.06.20 19:25:29
Kleine posi aufgebaut
Canopy Growth | 22,43 C$
Avatar
07.06.20 12:25:46
Bin hier nicht dabei aber vermutlich keine schlechte Entscheidung wenn man liest wie sich kritische und von vielen geschätzte Betrachter der Szene zu einigen Beverages, in dem Fall Deep Space, äußern. Die scheinen immer besser zu werden -> eine 7/10 👍 Da ist man von BB schon andere Kritik gewohnt 😂

Allen viel Glück 👍🍀

https://mobile.twitter.com/bettingbruiser

Betting Bruiser
@BettingBruiser
·
10 Std.
I’m speechless. I don’t need need to choke it down. Or pour it down the toilet. Taste like of cocoa cola candies with hint of Bubble gum tooth paste freshness. Maybe a poor man’s energy drink without sugar. But 7/10 overall $CGC $WEED #PotStocks

CGC hat ja bereits mit Constellation eine Größe aus dem Business hinter sich.

… ach ja und jeder hat mal klein angefangen!

Wie viele Dosen Red Bull werden jährlich verkauft?
Der Salzburger Energydrink-Riese Red Bull hat ein Rekordjahr hinter sich. Wie die "Kronen Zeitung" am Mittwoch berichtete, hat das Unternehmen 2018 weltweit 6,79 Milliarden Dosen verkauft - ein Plus von 7,7 Prozent. Der Umsatz stieg auf über 5,5 Milliarden Euro (plus 3,8 Prozent).
Canopy Growth | 14,59 €
1 Antwort
Avatar
07.06.20 12:27:45
Antwort auf Beitrag Nr.: 63.931.035 von Apprentice am 07.06.20 12:25:46… ich meinte keine schlechte Entscheidung von weedman eine kleine Position aufgebaut zu haben!
Canopy Growth | 14,59 €
Avatar
09.09.20 14:23:10
Antwort auf Beitrag Nr.: 63.071.227 von faultcode am 19.03.20 22:34:27ACB:



8.9.
Aurora Cannabis stock slides nearly 12% on news of up to $1.4 billion goodwill impairment charge
https://www.marketwatch.com/story/aurora-cannabis-stock-slid…

Aurora Cannabis Inc.’s stock tumbled nearly 12% Tuesday, after the Canadian company said it’s recording up to C$1.8 billion ($1.4 billion) of goodwill impairment charges on some of its past acquisitions.

Aurora had the most accumulated non-cash value on its balance sheet of the major cannabis companies, as MarketWatch reported in August 2019. Like its rivals, Aurora made a series of acquisitions in the early days of the cannabis boom and was expected to have to write down goodwill — the amount allocated to certain acquisitions beyond the value of their physical assets — at some point.

Aurora had accumulated C$2.11 billion from its acquisition of Medreleaf, which closed in July 2018; C$712.1 million from its purchase of Cannimed Theraputics in March 2018; and C$137.2 million from the acquisition of ICC Labs in November 2018, according to its public financial statements.

The company is also taking fixed asset impairment charges of up to C$90 million, and is writing down up to C$140 million on certain inventory, mostly trim, to better align it with near-term demand expectations.


The company expects to book a $30 million charge to terminate a contract with mixed-martial arts company UFC in the first quarter of 2021. The companies had joined forces to advance clinical research on CBD products and athletes’ wellness. That deal was announced last summer with some fanfare and was intended to last eight years. Since that time, then-CEO Terry Booth has left and UFC canceled its events at the start of the pandemic.

Beset by losses, the company announced a business transformation plan back in February, that included Booth’s departure, job cuts and writedowns.

Aurora is amending credit agreements and now expects to generate positive adjusted EBITDA in the second quarter of fiscal 2021. It is continuing to cut costs as part of a transformation plan and expects fiscal fourth-quarter revenue to range from C$70 million to C$72 million, compared with a FactSet consensus of C$77 million.

The company has named Miguel Martin chief executive with immediate effect, replacing interim CEO Michael Singer, who will remain executive chairman. Martin is a former CEO of CBD company Reliva, who assumed the role of chief commercial officer of Aurora in July. Before that, the executive was president of Logic Technology, a maker of e-cigarettes. He has also done stints at Altria Inc. MO, -0.96%.
...
Canopy Growth | 13,44 €


Beitrag zu dieser Diskussion schreiben